Effects of Turkish Traditional Dances on Postmenopausal Osteopenic Women
1 other identifier
interventional
81
1 country
1
Brief Summary
The aim of this study is to evaluate the effects of regular Turkish regional dances, in addition to conventional exercises given with a home program, on the quality of life, balance, aerobic capacity, bone mineral density (femoral neck, total and lumbar L1-4 and L2-4 T scores) and bone turnover markers (Type 1 collagen C-telopeptide \[CTX-1\] and Serum Procollagen 1 N-terminal peptide \[P1NP\]) of postmenopausal osteopenic women aged 50-60 years. Our study also aims to evaluate the compliance of patients to the exercise programs given to postmenopausal osteopenic women.
- What is the effect of regular Turkish regional dances on balance, aerobic capacity, muscle strength, quality of life, Bone Mineral Densitometry and Bone Turnover Markers in postmenopausal osteopenic women?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 19, 2025
CompletedFirst Submitted
Initial submission to the registry
July 4, 2025
CompletedFirst Posted
Study publicly available on registry
July 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2026
CompletedMarch 12, 2026
July 1, 2025
12 months
July 4, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Bone Turnover Markers(Type 1 collagen C-telopeptide)
Serum Type 1 collagen C-telopeptide (CTX-1) will be used for bone resorption.
three month
Bone Turnover Markers(Serum Procollagen 1 N-terminal peptide)
Serum Procollagen 1 N-terminal peptide (P1NP) will be used for bone formation
three month
Bone Mineral Density(Femoral Neck T scores)
In our study, femoral neck T scores bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry .Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).
six month
Bone Mineral Density(Femoral total T scores)
In our study, femoral total T scores and bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry.Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).
six month
bone mineral density(lumbar 1-4 Tscores)
In our study, lumbar 1-4 T scores bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry .Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).
six month
bone mineral density(lumbar 2-4 T scores)
In our study, lumbar 2-4 T scores bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry .Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).
six month
Secondary Outcomes (4)
BALANCE
three month
muscle strength
three month
aerobic capacity
three month
quality of life measurement
three month
Study Arms (2)
EXERCISE GROUP
ACTIVE COMPARATORPatients are asked to do a home exercise program 3-5 days a week In addition to the exercises, they are asked to walk only 3 days a week, a total of at least 150 minutes per week
DANCE GROUP
ACTIVE COMPARATORA home exercise program will be done 3-5 days a week In addition to home exercises, patients will be asked to dance with a tempo determined by the study team before the study, lasting 30 minutes, accompanied by dance videos from various regions Before the dance, 10 minutes of WARM-UP EXERCISES will be asked, followed by 30 minutes of dance and 10 minutes of COOL-DOWN EXERCISES. Thus, it is aimed for you to dance at least 50 minutes at least 2 days a week. In addition, it is asked to walk at least 50 minutes at a pace once a week
Interventions
Eligibility Criteria
You may qualify if:
- Being a postmenopausal woman between the ages of 50-60
- Not having a known diagnosis of osteoporosis and not having taken any antiresorptive or anabolic agents before
- Being diagnosed with osteopenia with DEXA taken in the last 6 months at Etlik City Hospital (femoral neck, femoral total L1-4 or L2-4 T score between -1 and -2.5)
- Being literate
- Having a 25-Hydroxy vitamin D level in the blood \>20 µg/L
- Having a phone that can be used for communication for oneself or one of the family members, as well as having a smart phone, tablet or computer that can be used to watch videos
- Being willing to participate in the study
You may not qualify if:
- Having a body mass index \>30 kg/m2
- Having an extremely sedentary lifestyle (International Physical Activity Scale-Inactive according to Short Form)
- Presence of fragility fracture
- Presence of malignancy
- Presence of cardiovascular or respiratory system disease that will prevent exercise (unstable angina, uncontrolled atrial or ventricular arrhythmia, 3rd degree atrioventricular block, severe aortic stenosis, severe asthma-COPD)
- Presence of current neurological disease that will prevent exercise (CVA, MS)
- Presence of psychiatric disease that will prevent exercise or cause non-compliance in follow-ups
- Presence of musculoskeletal system disease that will prevent exercise (Stage 3-4 osteoarthritis, severe spinal stenosis, severe radiculopathy, lumbar surgery within the last 1 year)
- Presence of known inflammatory joint disease
- Presence of advanced vision, hearing loss or vertigo etc. that will prevent the patient from doing exercises or regional dances. Having any disease that will disrupt harmony by causing balance problems
- Using active estrogen or progesterone containing preparations
- Presence of hyperthyroidism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik Ciy Hospital
Ankara, Yenimahalle, 060000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RESEARCH ASSISTANT
Study Record Dates
First Submitted
July 4, 2025
First Posted
July 16, 2025
Study Start
February 19, 2025
Primary Completion
February 15, 2026
Study Completion
February 15, 2026
Last Updated
March 12, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share